High-intensity Focused Ultrasound (HIFU) Market Is Prospering Owing To The Rising Prevalence of Chronic Diseases All Over The World

Global High-Intensity Focused Ultrasound (HIFU) Market was valued at ~US$ 100 million in 2020 and is expected to grow at a CGAR of ~18% over the forecast period (2021-2027). Focused ultrasound is an initial phase, noninvasive therapeutic technology which improves the lives of millions of patients suffering from serious medical conditions.

The demand for High-intensity focused ultrasound (HIFU) market is increasing on account of the high prevalence of cancer as well as cardiovascular disease cases, promulgating aging population, increasing number of new product launches, mounting number of clinical trials, and high focus of market key players on the development of technologically advanced systems. As per the International Agency for Research on Cancer (IARC), 1 in 5 people develop cancer during their lifetime globally and 1 in 11 women die from cancer. Cancer cases are continuously increasing on account of the lifestyle changes, rise in the geriatric population, and socioeconomic risk factors. Breast cancer accounts for the highest prevalence in the case of women owing to the genetic mutations in the BRCA1 and BRCA2 gene, radiation exposure, obesity, and postmenopausal hormonal therapy.

For a detailed analysis of the market drivers in High-intensity Focused Ultrasound (HIFU) browse through https://univdatos.com/get-a-free-sample-form-php/?product_id=11213

Based on Modality, the market is fragmented into Therapeutic Ultrasound, Hemostasis, Lithotripsy, Thrombolysis, Immunomodulation, and Others. The therapeutic ultrasound segment dominated the market in 2020 and is expected to grow at lucrative during the forecasted period. Therapeutic ultrasound is a kind of treatment modality that is mainly exploited during physical therapy to joints, tissue, muscles, tendons, and ligaments. It mainly provides deep heating to heel the soft tissues of the body.

Based on Methods, the market is bifurcated into Non-invasive Methods and Minimal Invasive Methods. The non-invasive segment dominated the market in 2020 and is expected to grow at lucrative during the forecasted period. Non-Invasive ultrasound stimulation is a developing technology that can noninvasively inhibit neural activity in the targeted brain by delivering pulsed ultrasonic waves. The increasing occurrence of the neurological, orthopedic, tooth, and gastrointestinal health problems among various chronic disorders is anticipated to create an upsurge in demand for non-invasive methods.

For a detailed analysis of Temperature Type in High-intensity Focused Ultrasound (HIFU) browse through https://univdatos.com/get-a-free-sample-form-php/?product_id=11213

For a better understanding of the market adoption of High-intensity focused ultrasound (HIFU), the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America will dominate the High-intensity focused ultrasound (HIFU) market on account of the due to growing prevalence of cancers in this region, which is one of the major driving factors for the growth of high intensity focused ultrasound (HIFU) therapy market. Some of the major players operating in the market include Medtronic, Inc., Accutome, Inc., Sonacare Medical, Koninklijke Philips N.V., Johnson & Johnson, Stryker Corporation, Supersonic Imagine, Ultrasound Technologies Ltd., and Blatek, Inc. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions.

Global High-intensity Focused Ultrasound (HIFU) Market Segmentation

Market Insight, by Modality

• Market Insight, by Methods

• Market Insight, by Application

• Prostate Cancer
• Uterine Fibroids
• Neurological Disorders
• Cosmetic Medicine
• Others

Market Insight, by End-Users

• Diagnostic Centers
• Hospitals
• Research Centers
• Others

Market Insight, by Region

• North America
  • United States
  • Canada
  • Rest of North America
• Europe
  • Germany
  • United Kingdom
  • France
  • Spain
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia-Pacific
• Rest of World

Top Company Profiles

• Medtronic, Inc.
• Accutome, Inc.
• Sonacare Medical
• Koninklijke Philips N.V.
• Johnson & Johnson
• Stryker Corporation
• Supersonic Imagine
• Ultrasound Technologies Ltd.
• Blatek, Inc.